StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock.
Pulmatrix Stock Up 8.0 %
NASDAQ:PULM opened at $1.75 on Friday. The stock’s fifty day moving average is $1.80 and its two-hundred day moving average is $1.90. Pulmatrix has a 52 week low of $1.55 and a 52 week high of $3.15. The stock has a market capitalization of $6.39 million, a price-to-earnings ratio of -0.45 and a beta of 0.95.
Institutional Trading of Pulmatrix
Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Pulmatrix by 62.9% in the fourth quarter. Vanguard Group Inc. now owns 35,082 shares of the biotechnology company’s stock valued at $65,000 after buying an additional 13,548 shares during the last quarter. Susquehanna International Group LLP purchased a new position in shares of Pulmatrix during the 1st quarter worth approximately $73,000. Mariner LLC purchased a new stake in Pulmatrix in the 4th quarter worth approximately $97,000. Citadel Advisors LLC purchased a new stake in shares of Pulmatrix during the 2nd quarter valued at $141,000. Finally, Renaissance Technologies LLC lifted its holdings in Pulmatrix by 7.3% in the 2nd quarter. Renaissance Technologies LLC now owns 121,920 shares of the biotechnology company’s stock worth $560,000 after buying an additional 8,300 shares in the last quarter. 11.84% of the stock is currently owned by institutional investors and hedge funds.
About Pulmatrix
Pulmatrix, Inc, a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Read More
- Five stocks we like better than Pulmatrix
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 3/25-3/29
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Stock Dividend Cuts Happen Are You Ready?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.
